NRC
NASDAQ · Health Care
National Research Corp
$26.56
-0.08 (-0.30%)
Financial Highlights (FY 2026)
Revenue
126.74M
Net Income
10.70M
Gross Margin
61.9%
Profit Margin
8.4%
Rev Growth
-3.2%
D/E Ratio
5.65
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 61.9% | 61.9% | 67.8% | 67.8% |
| Operating Margin | 16.4% | 14.8% | 8.7% | 11.1% |
| Profit Margin | 8.4% | 8.0% | 8.0% | 10.0% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 126.74M | 130.97M | 186.15M | 191.25M |
| Gross Profit | 78.43M | 81.04M | 126.15M | 129.60M |
| Operating Income | 20.84M | 19.38M | 16.29M | 21.21M |
| Net Income | 10.70M | 9.95M | 14.97M | 19.17M |
| Gross Margin | 61.9% | 61.9% | 67.8% | 67.8% |
| Operating Margin | 16.4% | 14.8% | 8.7% | 11.1% |
| Profit Margin | 8.4% | 8.0% | 8.0% | 10.0% |
| Rev Growth | -3.2% | -3.2% | -4.1% | -8.3% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 233.81M | 233.81M | 19.99M | 16.96M |
| Total Equity | 41.38M | 41.38M | 255.25M | 239.89M |
| D/E Ratio | 5.65 | 5.65 | 0.08 | 0.07 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 27.87M | 27.36M | 21.30M | 22.66M |
| Free Cash Flow | — | — | 13.38M | 16.98M |